Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?

Cleveland Clinic Rheumatology

L. Calabrese, G. Hoffman

GI Manifestations of Rheumatologic Disorders in Women

Jefferson Health

C. Choudhary

EADV Highlights: IgA Associated Vasculitis

Hok Bing Thio

The Cat in Wolves Clothing – Is It ANCA Vasculitis or Bartonella & M…

Cleveland Clinic Rheumatology

A. Brown

GPA and MPA: Is There Still a Role for Conventional Therapy? - Part 2

Cleveland Clinic Rheumatology

C. Langford

A Case of GPA With Persistent Shortness of Breath, Monitoring Patien…

Cleveland Clinic Rheumatology

A. Villa-Forte

AAV Induction Therapy Update: Is Cyclophosphamide (CP) Crucial for P…

Hospital for Special Surgery

L. Lally

Checkpoint Inhibitors and Rheumatic Disease

NYU Langone

A. Bass

ACR Convergence 2023 Highlights: Abstract Recap Panel - Wednesday

RheumNow

J. Pope, R. Conway, M. Ramahi, J. Cush

EADV 2023 Insights: Infectious Granulomatous Skin Diseases

EADV 2023 Insights

E. Laffitte

When Should Biologic Agents be Considered in Eosinophilic Granulomat…

Cleveland Clinic Rheumatology

M. Wechsler

ACR Convergence 2023 Highlights: Abstract Recap Panel - Monday

RheumNow

K. Dao, M. Putman, E. Dein, J. Cush

COVID-19 and Multi-system Inflammatory Syndrome in Children (MIS-C):…

Northwestern Medicine Cardiovascular Care

A. Zajarias, J. Hermiller, D. Balzer

EGPA: Challenges and Prognosis

Cleveland Clinic Rheumatology

R. Hajj-Ali

GPA Management in 2024

RheumNow

A. Dua

ANCA-Associated Vasculitis Treated with Avacopan versus a Standard P…

Naomi Patel

EADV 2023 Insights: Neonatal Dermatologic Emergencies: What Should W…

EADV 2023 Insights

N. Moftah

2021 RWCS Highlights on Cytokine Release Syndrome, Kawasaki's Diseas…

RheumNow

J. Cush, A. Kavanaugh

Clinical Spectrum of AAV: Which are Associated Vasculitises? What ar…

Hospital for Special Surgery

L. Lally

Could EGPA be Treated with Biologics?

Cleveland Clinic Rheumatology

M. Wechsler